期刊文献+

法舒地尔对ApoE^(-/-)小鼠动脉粥样硬化斑块的影响 被引量:4

Anti-atherogenic effects and mechanism of fasudil on ApoE^(-/-) mice
下载PDF
导出
摘要 目的观察特异性Rho激酶抑制剂法舒地尔对载脂蛋白E基因敲除(ApoE-/-)小鼠动脉粥样硬化斑块进展的影响,并探讨其可能的作用机制。方法8周龄ApoE-/-小鼠高脂饲料喂养12周后给予法舒地尔干预,12周后结束实验。将ApoE-/-小鼠随机分为三组(n=10):对照组(饮用水)、法舒地尔低剂量组(30mg·kg-1.d-1)和法舒地尔高剂量组(100mg·kg-1.d-1)。在实验结束时,测量小鼠体质量、血压及血脂水平;对头臂干动脉粥样硬化病变进行病理学检查;化学发光法及组织荧光法检测小鼠胸主动脉超氧阴离子和活性氧(ROS)。结果法舒地尔干预对ApoE-/-小鼠体质量、收缩压及血脂水平均无明显影响。与对照组相比,法舒地尔高剂量组头臂干动脉粥样硬化斑块面积和动脉内-中膜厚度(IMT)分别减少54%(P<0.01)和42%(P<0.05)。法舒地尔干预使ApoE-/-小鼠胸主动脉原位ROS的生成较对照组明显减少(P<0.01);法舒地尔高剂量组胸主动脉的超氧阴离子产量低于对照组(P<0.05)。结论阻断Rho激酶可抑制ApoE-/-小鼠头臂干动脉粥样硬化斑块的进展,其作用独立于血压和血脂水平,可能与抗氧化应激有关。 Objective To examine the effects of fasudil,a specific Rho kinase inhibitor,on atherosclerotic plaque progression in apolipoprotein E-deficient(ApoE^-/-)mice,and explore the potential mechanisms.Methods After 12 weeks of fat-feeding,ApoE^-/-mice were orally administrated with fasudil for 12 weeks.Mice were randomly allocated into three groups:control group(tap water),low-dose fasudil group(30 mg·kg^-1·d^-1)and high-dose fasudil group(100 mg·kg^-1·d^-1)(n=10 in each group).At the end of the study,body weight,blood pressure and blood lipid were measured,and atherosclerosis of brachiocephalic arteries were determined by histological examinations.Production of superoxide anion and reactive oxygen species(ROS)were measured in the thoracic aorta of mice using chemiluminescence and histofluorescence techniques.Results Fasudil treatment had no effect on body weight,blood pressure and blood lipid concentrations of ApoE^-/-mice.The plaque area and intima-medial thickness of brachiocephalic artery were attenuated by 54% and 42%,respectively in high-dose fasudil group in comparison with control group(P〈0.01 and P〈0.05,respectively).Furthermore,fasudil treatment significantly reduced in situ ROS production of thoracic aorta(P〈0.01).And the production of superoxide anion in the aortic wall was lower in high-dose fasudil group than in control group(P〈0.05).Conclusion Blocking Rho kinase may inhibit the progression of atherosclerotic plaques of brachiocephalic arteries in ApoE^-/-mice,and the effect may be independent of blood pressure and blood lipid changes,while probably be related with the anti-oxidative stress effect.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2009年第9期1026-1029,1048,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家重点基础研究发展计划("973"计划)(2004CB518603) 上海市科委基金(08JC1417400 08DZ2200400 08410701900)~~
关键词 法舒地尔 动脉粥样硬化 氧化应激 小鼠 fasudil atherosclerosis oxidative stress mice
  • 相关文献

参考文献14

  • 1Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25(9): 1767- 1775.
  • 2Rikitake Y, Liao JK. ROCKs as therapeutic targets in cardiovascular diseases[J]. Expert Rev Cardiovasc Ther, 2005, 3 (3): 441 - 451.
  • 3Mallat Z, Gojova A, Sauzeau V, et al. Rho-associated protein kinase contributes to early atherosclerotic lesion formation in mice[ J]. Circ Res, 2003, 93 (9) : 884 - 888.
  • 4Rivera P, Ocaranza MP, Lavandero S, et al. Rho kinase activation and gene expression related to vascular remodeling in normotensive rats with high angiotensin I converting enzyme levels [ J ]. Hypertension, 2007, 50 (4): 792- 798.
  • 5Johnson J, Carson K, Williams H, et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment[ J]. Circulation, 2005, 111(11): 1422-1430.
  • 6Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion produetion [J]. J Clin Invest, 1993, 91(6) : 2546 -2551.
  • 7Higashi M, Shimokawa H, Hattori T, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-indueed cardiovascular hypelltrophy in rats in vivo : effect on endothelial NAD(P) H oxidase system[J]. CireRes, 2003, 93(8): 767 -775.
  • 8Kanda T, Hayashi K, Wakino S, et al. Role of Rho-kinase and p27 in angiotensin II induced vascular injury[ J]. Hypertension, 2005, 45(4) : 724 -729.
  • 9Wang YX, Martin-McNulty B, da Cunha V, et al. Fasudil, a Rhokinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis[ J ]. Circulation, 2005, 111 ( 17 ) : 2219 - 2226.
  • 10Budzyn K, Sobey CG. Vascular rho kinases and their potential therapeutic applications[ J]. Curr Opin Drug Discov Devel, 2007, 10(5) : 590 -596.

同被引文献40

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部